SARS-COV2: Clinical Trials

6 trials for SARS-COV2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 21Completed 1

Follow SARS-COV2: new trials by email Literature Review of SARS-COV2 trials Research Report on SARS-COV2

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients
Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour, Placebo of NICOTINE Transdermal patch - SARS-COV2
Phase 3CompletedAssistance Publique - Hôpitaux de Paris322020-12-092022-02-11
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff
Bamlanivimab, Placebo, Etesevimab - COVID-19, SARS-CoV2
Phase 3CompletedEli Lilly and Company11802020-08-022022-02-04
Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation
Vitamins, Telmisartan, Ciclesonide - Corona Virus Infection, Sars-CoV2
Phase 2 / Phase 3CompletedUniversity Hospital, Bordeaux4122020-07-292026-05-12
BCG Vaccination for Healthcare Workers in COVID-19 Pandemic
Bacille Calmette-Guérin (BCG), Placebo Comparator - COVID-19, Sars-CoV2
Phase 3CompletedTASK Applied Science10002020-05-042022-01-25
Honey & Nigella Sativa Trial Against COVID-19
Honey, Nigella Sativa / Black Cumin, Placebos - Coronavirus Infection, Sars-CoV2
Phase 3CompletedSohaib Ashraf3132020-04-302020-11-12
Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients
Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin - Sars-CoV2, COVID
Phase 3CompletedNorthwell Health2572020-04-262021-11-22

Narrower conditions

COVID-19 (5)  ·  Coronavirus Infections (3)  ·  Thrombosis (1)

Broader conditions

Coronaviridae Infections (6)  ·  Infections (6)  ·  Nidovirales Infections (6)  ·  RNA Virus Infections (6)  ·  Virus Diseases (6)  ·  Lung Diseases (5)  ·  Pneumonia (5)  ·  Pneumonia, Viral (5)  ·  Respiratory Tract Diseases (5)  ·  Respiratory Tract Infections (5)  ·  Coronavirus Infections (3)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Vascular Diseases (1)

Interventions

Dalteparin (1)  ·  Enoxaparin (1)  ·  Heparin (1)  ·  Honey (1)  ·  Nicotine (1)  ·  Sodium Chloride (1)  ·  Telmisartan (1)  ·  Transdermal Patch (1)  ·  Vitamins (1)  ·  bamlanivimab (1)  ·  ciclesonide (1)  ·  etesevimab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Eli Lilly and Company (1)  ·  Northwell Health (1)  ·  Sohaib Ashraf (1)  ·  TASK Applied Science (1)  ·  University Hospital, Bordeaux (1)

Countries

France (2)  ·  United States (2)  ·  Pakistan (1)  ·  South Africa (1)

Top investigators

Alex C Spyropoulos, MD (1)  ·  Ayesha Hamayun, MBBS, PhD (1)  ·  Muhammad Ahmad Imran, MBBS (1)  ·  Muhammad Ashraf, DVM, PhD (1)  ·  Shoaib Ashraf, PhD (1)  ·  Sohaib Ashraf, MBBS (1)

Results publications

PMID 34473343, PMID 33050924, PMID 33502773, PMID 33591017, PMID 34081073, PMID 34374951, PMID 34617959, PMID 35244208, PMID 35582122, PMID 35713300, PMID 36420866, PMID 37401774, PMID 37591523, PMID 38454482